The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Open accessAbstract
The acronym ESKAPE includes six nosocomial pathogens that exhibit multidrug resistance and virulence: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. Persistent use of antibiotics has provoked the emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) bacteria, which render even the most effective drugs ineffective. Extended spectrum β-lactamase (ESBL) and carbapenemase producing Gram negative bacteria have emerged as an important therapeutic challenge. Development of novel therapeutics to treat drug resistant infections, especially those caused by ESKAPE pathogens is the need of the hour. Alternative therapies such as use of antibiotics in combination or with adjuvants, bacteriophages, antimicrobial peptides, nanoparticles and photodynamic light therapy are widely reported. Many reviews published till date describe these therapies with respect to the various agents used, their dosage details and mechanism of action against MDR pathogens but very few have focused specifically on ESKAPE. The objective of this review is to describe the alternative therapies reported to treat ESKAPE infections, their advantages and limitations, potential application in vivo and status in clinical trials. The review further highlights the importance of a combinatorial approach, wherein two or more therapies are used in combination in order to overcome their individual limitations, additional studies on which are warranted, before translating them into clinical practice. These advances could possibly give an alternate solution or extend the lifetime of current antimicrobials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30753-3 · Cited by 6,142
Allegranzi, B., Nejad, S. B., Combescure, C., Graafmans, W., Attar, H., Donaldson, L., & Pittet, D. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61458-4 · Cited by 2,514
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,310
Mechanistic Basis of Antimicrobial Actions of Silver Nanoparticles
Dakal, T. C., Kumar, A., Majumdar, R. S., & Yadav, V. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01831 · Cited by 2,135
Persister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052
New photosensitizers for photodynamic therapy
Abrahamse, H., & Hamblin, M. R. (2016) · Biochemical Journal · doi:10.1042/bj20150942 · Cited by 2,033
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00194 · Cited by 1,927
Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens
Santajit, S., & Indrawattana, N. (2016) · BioMed Research International · doi:10.1155/2016/2475067 · Cited by 1,641
Clinical relevance of the ESKAPE pathogens
Pendleton, J. N., Gorman, S. P., & Gilmore, B. F. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.12 · Cited by 1,423
A review on biosynthesis of silver nanoparticles and their biocidal properties
Siddiqi, K. S., Husen, A., & Rao, R. A. K. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0334-5 · Cited by 1,330
Genetic Analysis of Human Norovirus Strains in Japan in 2016–2017
Nagasawa, K., Matsushima, Y., Motoya, T., Mizukoshi, F., Ueki, Y., Sakon, N., Murakami, K., Shimizu, T., Okabe, N., Nagata, N., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00001 · Cited by 1,257
Schooley, R. T., Biswas, B., Gill, J. J., Hernandez-Morales, A., Lancaster, J., Lessor, L., Barr, J. J., Reed, S. L., Rohwer, F., Benler, S., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00954-17 · Cited by 1,254
Phage therapy: An alternative to antibiotics in the age of multi-drug resistance
Lin, D. M., Koskella, B., & Lin, H. C. (2017) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v8.i3.162 · Cited by 1,135
Phage treatment of human infections
Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011) · Bacteriophage · doi:10.4161/bact.1.2.15845 · Cited by 980
Phage Cocktails and the Future of Phage Therapy
Chan, B. K., Abedon, S. T., & Loc-Carrillo, C. (2013) · Future Microbiology · doi:10.2217/fmb.13.47 · Cited by 914
Antimicrobial photodynamic therapy – what we know and what we don’t
Cieplik, F., Deng, D., Crielaard, W., Buchalla, W., Hellwig, E., Al-Ahmad, A., & Maisch, T. (2018) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2018.1467876 · Cited by 902
Jault, P., Leclerc, T., Jennes, S., Pirnay, J. P., Que, Y.-A., Resch, G., Rousseau, A. F., Ravat, F., Carsin, H., Le Floch, R., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30482-1 · Cited by 874
Alternative Antimicrobial Approach: Nano-Antimicrobial Materials
Beyth, N., Houri-Haddad, Y., Domb, A., Khan, W., & Hazan, R. (2015) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2015/246012 · Cited by 837
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
Chan, B. K., Sistrom, M., Wertz, J. E., Kortright, K. E., Narayan, D., & Turner, P. E. (2016) · Scientific Reports · doi:10.1038/srep26717 · Cited by 715
Founou, R. C., Founou, L. L., & Essack, S. Y. (2017) · PLOS ONE · doi:10.1371/journal.pone.0189621 · Cited by 710
Wittebole, X., De Roock, S., & Opal, S. M. (2014) · Virulence · doi:10.4161/viru.25991 · Cited by 599
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy
Malik, D. J., Sokolov, I. J., Vinner, G. K., Mancuso, F., Cinquerrui, S., Vladisavljevic, G. T., Clokie, M. R. J., Garton, N. J., Stapley, A. G. F., & Kirpichnikova, A. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.05.014 · Cited by 594
The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms
de Breij, A., Riool, M., Cordfunke, R. A., Malanovic, N., de Boer, L., Koning, R. I., Ravensbergen, E., Franken, M., van der Heijde, T., Boekema, B. K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan4044 · Cited by 555
Nanomaterials for alternative antibacterial therapy
Hemeg, H. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s132163 · Cited by 550
Chopade, B., Ghosh, Patil, Ahire, Kitture, Jabgunde, Kale, Pardesi, Cameotra, Bellare, et al. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s24793 · Cited by 517
Antimicrobial Photodynamic Therapy to Control Clinically Relevant Biofilm Infections
Hu, X., Huang, Y.-Y., Wang, Y., Wang, X., & Hamblin, M. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01299 · Cited by 502
Phage treatment of an aortic graft infected with Pseudomonas aeruginosa
Chan, B. K., Turner, P. E., Kim, S., Mojibian, H. R., Elefteriades, J. A., & Narayan, D. (2018) · Evolution, Medicine, and Public Health · doi:10.1093/emph/eoy005 · Cited by 501
Antimicrobial Peptides for Therapeutic Applications: A Review
Seo, M.-D., Won, H.-S., Kim, J.-H., Mishig-Ochir, T., & Lee, B.-J. (2012) · Molecules · doi:10.3390/molecules171012276 · Cited by 492
Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds
Pfalzgraff, A., Brandenburg, K., & Weindl, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00281 · Cited by 481
Biswas, B., Adhya, S., Washart, P., Paul, B., Trostel, A. N., Powell, B., Carlton, R., & Merril, C. R. (2002) · Infection and Immunity · doi:10.1128/iai.70.1.204-210.2002 · Cited by 467
Durante-Mangoni, E., Signoriello, G., Andini, R., Mattei, A., De Cristoforo, M., Murino, P., Bassetti, M., Malacarne, P., Petrosillo, N., Galdieri, N., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit253 · Cited by 405
Novel Asymmetric Wettable AgNPs/Chitosan Wound Dressing: In Vitro and In Vivo Evaluation
Liang, D., Lu, Z., Yang, H., Gao, J., & Chen, R. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b11160 · Cited by 403
Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms
Chaudhry, W. N., Concepción-Acevedo, J., Park, T., Andleeb, S., Bull, J. J., & Levin, B. R. (2017) · PLOS ONE · doi:10.1371/journal.pone.0168615 · Cited by 394
Pirnay, J.-P., Verbeken, G., Ceyssens, P.-J., Huys, I., De Vos, D., Ameloot, C., & Fauconnier, A. (2018) · Viruses · doi:10.3390/v10020064 · Cited by 347
Mohanty, S., Mishra, S., Jena, P., Jacob, B., Sarkar, B., & Sonawane, A. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.11.007 · Cited by 344
Phage-Mediated Intergeneric Transfer of Toxin Genes
Chen, J., & Novick, R. P. (2009) · Science · doi:10.1126/science.1164783 · Cited by 314
Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options
Chatterjee, M., Anju, C. P., Biswas, L., Anil Kumar, V., Gopi Mohan, C., & Biswas, R. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2015.11.004 · Cited by 312
Biofilm formation and antibiotic resistance in Klebsiella pneumoniae urinary strains
Vuotto, C., Longo, F., Pascolini, C., Donelli, G., Balice, M. P., Libori, M. F., Tiracchia, V., Salvia, A., & Varaldo, P. E. (2017) · Journal of Applied Microbiology · doi:10.1111/jam.13533 · Cited by 300
Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
Domalaon, R., Idowu, T., Zhanel, G. G., & Schweizer, F. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00077-17 · Cited by 285
PHACTS, a computational approach to classifying the lifestyle of phages
McNair, K., Bailey, B. A., & Edwards, R. A. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts014 · Cited by 269
Alternatives to overcoming bacterial resistances: State-of-the-art
Rios, A. C., Moutinho, C. G., Pinto, F. C., Del Fiol, F. S., Jozala, A., Chaud, M. V., Vila, M. M. D. C., Teixeira, J. A., & Balcão, V. M. (2016) · Microbiological Research · doi:10.1016/j.micres.2016.04.008 · Cited by 263
Antibiotic adjuvants – A strategy to unlock bacterial resistance to antibiotics
González-Bello, C. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.08.027 · Cited by 254
Antibiotic adjuvants: multicomponent anti-infective strategies
Kalan, L., & Wright, G. D. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001766 · Cited by 249
Jennes, S., Merabishvili, M., Soentjens, P., Pang, K. W., Rose, T., Keersebilck, E., Soete, O., François, P.-M., Teodorescu, S., Verween, G., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1709-y · Cited by 248
Viertel, T. M., Ritter, K., & Horz, H.-P. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku173 · Cited by 243
Markoishvili, K., Tsitlanadze, G., Katsarava, R., Glenn, J., Morris Jr., M. D., & Sulakvelidze, A. (2002) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2002.01451.x · Cited by 243
Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site Infection
LaVergne, S., Hamilton, T., Biswas, B., Kumaraswamy, M., Schooley, R. T., & Wooten, D. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy064 · Cited by 239
Bacteriophage treatment of intransigent diabetic toe ulcers: a case series
Fish, R., Kutter, E., Wheat, G., Blasdel, B., Kutateladze, M., & Kuhl, S. (2016) · Journal of Wound Care · doi:10.12968/jowc.2016.25.7.s27 · Cited by 222
Treatment of experimental infections of mice with bacteriophages
SOOTHILL, J. S. (1992) · Journal of Medical Microbiology · doi:10.1099/00222615-37-4-258 · Cited by 220
Collagen nanofiber containing silver nanoparticles for improved wound-healing applications
Rath, G., Hussain, T., Chauhan, G., Garg, T., & Goyal, A. K. (2016) · Journal of Drug Targeting · doi:10.3109/1061186x.2015.1095922 · Cited by 220
Pletzer, D., Mansour, S. C., & Hancock, R. E. W. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007084 · Cited by 211
Rohde, C., Resch, G., Pirnay, J.-P., Blasdel, B., Debarbieux, L., Gelman, D., Górski, A., Hazan, R., Huys, I., Kakabadze, E., et al. (2018) · Viruses · doi:10.3390/v10040178 · Cited by 210
Bacteriophages: Protagonists of a Post-Antibiotic Era
Domingo-Calap, P., & Delgado-Martínez, J. (2018) · Antibiotics · doi:10.3390/antibiotics7030066 · Cited by 209
Nowak, J., Zander, E., Stefanik, D., Higgins, P. G., Roca, I., Vila, J., McConnell, M. J., Cisneros, J. M., Seifert, H., & MagicBullet Working Group WP4 (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx322 · Cited by 207
Tegos, G. P., & Hamblin, M. R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.196-203.2006 · Cited by 195
Berglund, N. A., Piggot, T. J., Jefferies, D., Sessions, R. B., Bond, P. J., & Khalid, S. (2015) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004180 · Cited by 190
Regeimbal, J. M., Jacobs, A. C., Corey, B. W., Henry, M. S., Thompson, M. G., Pavlicek, R. L., Quinones, J., Hannah, R. M., Ghebremedhin, M., Crane, N. J., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02877-15 · Cited by 187
Jun, S. Y., Jang, I. J., Yoon, S., Jang, K., Yu, K.-S., Cho, J. Y., Seong, M.-W., Jung, G. M., Yoon, S. J., & Kang, S. H. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02629-16 · Cited by 184
Characterizing Phage Genomes for Therapeutic Applications
Philipson, C., Voegtly, L., Lueder, M., Long, K., Rice, G., Frey, K., Biswas, B., Cer, R., Hamilton, T., & Bishop-Lilly, K. (2018) · Viruses · doi:10.3390/v10040188 · Cited by 183
Ding, L., Shan, X., Zhao, X., Zha, H., Chen, X., Wang, J., Cai, C., Wang, X., Li, G., Hao, J., et al. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.11.040 · Cited by 182
Mekkawy, A., El-Mokhtar, M., Nafady, N., Yousef, N., Hamad, M., El-Shanawany, S., Ibrahim, E., & Elsabahy, M. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s124294 · Cited by 179
Dong, R.-H., Jia, Y.-X., Qin, C.-C., Zhan, L., Yan, X., Cui, L., Zhou, Y., Jiang, X., & Long, Y.-Z. (2016) · Nanoscale · doi:10.1039/c5nr08367b · Cited by 174
Amin, R. M., Bhayana, B., Hamblin, M. R., & Dai, T. (2016) · Lasers in Surgery and Medicine · doi:10.1002/lsm.22474 · Cited by 174
Designing improved active peptides for therapeutic approaches against infectious diseases
Gomes, B., Augusto, M. T., Felício, M. R., Hollmann, A., Franco, O. L., Gonçalves, S., & Santos, N. C. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.01.004 · Cited by 172
Qayyum, S., Oves, M., & Khan, A. U. (2017) · PLOS ONE · doi:10.1371/journal.pone.0181363 · Cited by 171
Silver bullets: A new lustre on an old antimicrobial agent
Möhler, J. S., Sim, W., Blaskovich, M. A. T., Cooper, M. A., & Ziora, Z. M. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.05.004 · Cited by 169
Halstead, F. D., Thwaite, J. E., Burt, R., Laws, T. R., Raguse, M., Moeller, R., Webber, M. A., & Oppenheim, B. A. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.00756-16 · Cited by 168
Liposome Entrapment of Bacteriophages Improves Wound Healing in a Diabetic Mouse MRSA Infection
Chhibber, S., Kaur, J., & Kaur, S. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00561 · Cited by 165
Singla, S., Harjai, K., Katare, O. P., & Chhibber, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153777 · Cited by 163
Adapted Bacteriophages for Treating Urinary Tract Infections
Ujmajuridze, A., Chanishvili, N., Goderdzishvili, M., Leitner, L., Mehnert, U., Chkhotua, A., Kessler, T. M., & Sybesma, W. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01832 · Cited by 163
Wang, S., Yan, C., Zhang, X., Shi, D., Chi, L., Luo, G., & Deng, J. (2018) · Biomaterials Science · doi:10.1039/c8bm00807h · Cited by 161
Design and Application of Antimicrobial Peptide Conjugates
Reinhardt, A., & Neundorf, I. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050701 · Cited by 160
Challenges and future prospects of antibiotic therapy: from peptides to phages utilization
Mandal, S. M., Roy, A., Ghosh, A. K., Hazra, T. K., Basak, A., & Franco, O. L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00105 · Cited by 159
Chadha, P., Katare, O. P., & Chhibber, S. (2017) · Burns · doi:10.1016/j.burns.2017.03.029 · Cited by 158
Wan, G., Ruan, L., Yin, Y., Yang, T., Ge, M., & Cheng, X. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s104166 · Cited by 155
Shalumon, K. T., Sheu, C., Chen, C., Chen, S., Jose, G., Kuo, C., & Chen, J. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.03.044 · Cited by 155
Long, S. W., Olsen, R. J., Mehta, S. C., Palzkill, T. G., Cernoch, P. L., Perez, K. K., Musick, W. L., Rosato, A. E., & Musser, J. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03622-14 · Cited by 152
Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae
Zowawi, H. M., Forde, B. M., Alfaresi, M. S., Alzarouni, A., Farahat, Y., Chong, T. M., Yin, W., Chan, K., Li, J., Schembri, M. A., et al. (2015) · Scientific Reports · doi:10.1038/srep15082 · Cited by 148
Corbett, D. F., Wise, A., Langley, T., Skinner, K., Trimby, E., Birchall, S., Dorali, A., Sandiford, S. K., Williams, J., Warn, P. A., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00200-17 · Cited by 148
Leitner, L., Sybesma, W., Чанішвілі, Н., Goderdzishvili, M., Chkhotua, A. B., Ujmajuridze, A., Schneider, M. P., Sartori, A. M., Mehnert, U., Bachmann, L. M., et al. (2017) · BMC Urology · doi:10.1186/s12894-017-0283-6 · Cited by 144
Wen, X., Zhang, X., Szewczyk, G. M., El‐Hussein, A., Huang, Y., Sarna, T., & Hamblin, M. R. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00467-17 · Cited by 141
Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model
Nath, G., Kishor, C., Mishra, R., Saraf, S., Kumar, M., & Srivastav, A. (2016) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.178615 · Cited by 138
Inhibitors of Bacterial Multidrug Efflux Pumps Potentiate Antimicrobial Photoinactivation
Tegos, G. P., Masago, K., Aziz, F., Higginbotham, A., Stermitz, F. R., & Hamblin, M. R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00006-08 · Cited by 137
Refractory Pseudomonas Bacteremia in a 2-Year-Old Sterilized by Bacteriophage Therapy
Duplessis, C. A., Biswas, B., Hanisch, B. R., Perkins, M., Henry, M. S., Quinones, J., Wolfe, D., Estrella, L. A., & Hamilton, T. (2017) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pix056 · Cited by 131
Chen, C., Chen, S.-H., Shalumon, K. T., & Chen, J. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.07.041 · Cited by 130
Zhang, Y., Dai, T., Wang, M., Vecchio, D., Chiang, L. Y., & Hamblin, M. R. (2015) · Nanomedicine · doi:10.2217/nnm.14.131 · Cited by 127
Prevention of ESKAPE pathogen biofilm formation by antimicrobial peptides WLBU2 and LL37
Lin, Q., Deslouches, B., Montelaro, R. C., & Di, Y. P. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.04.019 · Cited by 127
Sangaonkar, G. M., & Pawar, K. D. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.01.044 · Cited by 123
Increased multi-drug resistant Escherichia coli from hospitals in Khartoum state, Sudan
Ibrahim, M. E., Bilal, N., & Hamid, M. (2013) · African Health Sciences · doi:10.4314/ahs.v12i3.19 · Cited by 120
Current concepts in combination antibiotic therapy for critically ill patients
Baronia, A. K., & Ahmed, A. (2014) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.132495 · Cited by 116
Wang, Z., Zheng, P., Ji, W., Fu, Q., Wang, H., Yan, Y., & Sun, J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00934 · Cited by 113
Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections
Palavutitotai, N., Jitmuang, A., Tongsai, S., Kiratisin, P., & Angkasekwinai, N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193431 · Cited by 112
Kumar, K. V. S. H., Gill, J., Arora, S., & Khanna, S. (2016) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.192962 · Cited by 111
Combined Antimicrobial Activity of Photodynamic Inactivation and Antimicrobials–State of the Art
Woźniak, A., & Grinholc, M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00930 · Cited by 110
Akram, F. E., El-Tayeb, T. A.-A., Abou‐Aisha, K., & El-Azizi, M. (2016) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-016-0164-y · Cited by 109
Bacteriophages: the possible solution to treat infections caused by pathogenic bacteria
El‐Shibiny, A., & El-Sahhar, S. (2017) · Canadian Journal of Microbiology · doi:10.1139/cjm-2017-0030 · Cited by 107
Danis-Wlodarczyk, K. M., Vandenheuvel, D., Jang, H. B., Briers, Y., Olszak, T., Arabski, M., Wąsik, S., Drabik, M., Higgins, G., Tyrrell, J., et al. (2016) · Scientific Reports · doi:10.1038/srep28115 · Cited by 104
Synergistic antimicrobial effect of photodynamic therapy and ciprofloxacin
Ronqui, M. R., Coletti, T. M. S. F. D. A., de Freitas, L. M., Miranda, E. T., & Fontana, C. R. (2016) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2016.02.036 · Cited by 102
Antibiotic adjuvants: identification and clinical use
Bernal, P., Molina‐Santiago, C., Daddaoua, A., & Llamas, M. A. (2013) · Microbial Biotechnology · doi:10.1111/1751-7915.12044 · Cited by 101
Antimicrobial Photodynamic therapy enhanced by the peptide aurein 1.2
de Freitas, L. M., Lorenzón, E. N., Santos‐Filho, N. A., Zago, L. H. D. P., Uliana, M. P., de Oliveira, K. T., Cilli, E. M., & Fontana, C. R. (2018) · Scientific Reports · doi:10.1038/s41598-018-22687-x · Cited by 101
López-Cortés, L. F., Cisneros, J. M., Fernández-Cuenca, F., Bou, G., Tomás, M., Garnacho‐Montero, J., Pascual, Á., Martı́nez-Martı́nez, L., Vilà, J., Pachón, J., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku233 · Cited by 100
In Vitro Characteristics of Phages to Guide ‘Real Life’ Phage Therapy Suitability
Casey, E., van Sinderen, D., & Mahony, J. (2018) · Viruses · doi:10.3390/v10040163 · Cited by 100
Zeng, K.-J., Doi, Y., Patil, S., Huang, X., & Tian, G. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00345-16 · Cited by 99
Detection of pan drug-resistant Acinetobacter baumannii in Germany
Göttig, S., Gruber, T. M., Higgins, P. G., Wachsmuth, M., Seifert, H., & Kempf, V. A. J. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku170 · Cited by 96
Chang, R. Y. K., Chen, K., Wang, J., Wallin, M., Britton, W. J., Morales, S., Kutter, E. M., Li, J., & Chan, H. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01714-17 · Cited by 96
Vestergaard, M. R., Paulander, W., Marvig, R. L., Clasen, J., Jochumsen, N., Molin, S., Jelsbak, L., Ingmer, H., & Folkesson, A. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.09.014 · Cited by 95
Manohar, P., Nachimuthu, R., & Lopes, B. S. (2018) · BMC Microbiology · doi:10.1186/s12866-018-1234-4 · Cited by 95
Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa
Lin, Y., Chang, R. Y. K., Britton, W. J., Morales, S., Kutter, E. M., & Chan, H. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.024 · Cited by 95
The clinical importance of emerging ESKAPE pathogens in nosocomial infections
Navidinia, M. (2016) · Archives of Advances in Biosciences · doi:10.22037/jps.v7i3.12584 · Cited by 94
Peng, Y., Song, C., Yang, C., Guo, Q., & Yao, M. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s122357 · Cited by 89
Lee, N., Lee, C., Li, C., Li, M.-C., Chen, P., Chang, C., & Ko, W. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01477-15 · Cited by 83
Fila, G., Kawiak, A., & Grinholc, M. (2016) · Virulence · doi:10.1080/21505594.2016.1250995 · Cited by 83
Mai, B., Gao, Y., Li, M., Wang, X., Zhang, K., Liu, Q., Xu, C., & Wang, P. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s138185 · Cited by 83
Zheng, Z., Tharmalingam, N., Liu, Q., Jayamani, E., Kim, W., Fuchs, B. B., Zhang, R., Vilcinskas, A., & Mylonakis, E. E. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00686-17 · Cited by 81
Mann, N. H. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030182 · Cited by 80
Chibebe, J., Fuchs, B. B., Sabino, C. P., Junqueira, J. C., Jorge, A. O. C., Ribeiro, M. S., Gilmore, M. S., Rice, L. B., Tegos, G. P., Hamblin, M. R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055926 · Cited by 79
Costley, D., Nesbitt, H., Ternan, N., Dooley, J., Huang, Y.-Y., Hamblin, M. R., McHale, A., & Callan, J. F. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.09.034 · Cited by 79
Antonelli, M. M., PASCALE, G. D., Ranieri, V. M., Pelaia, P., Tufano, R., Piazza, O., Zangrillo, A., Ferrario, A., Gaetano, A. D., Guaglianone, E., et al. (2012) · Journal of Hospital Infection · doi:10.1016/j.jhin.2012.07.010 · Cited by 78
Gaglione, R., Dell’Olmo, E., Bosso, A., Chino, M., Pane, K., Ascione, F., Itri, F., Caserta, S., Amoresano, A., Lombardi, A., et al. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.01.009 · Cited by 78
Verbelen, J., Hoeksema, H., Heyneman, A., et al. (2013) · Burns · doi:10.1016/j.burns.2013.07.008 · Cited by 77
Tomb, R., Maclean, M., Coia, J. E., MacGregor, S. J., & Anderson, J. G. (2017) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-017-0261-5 · Cited by 74
Zhou, W., Feng, Y., & Zong, Z. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00850 · Cited by 74
Biocompatibility of Antimicrobial Melimine Lenses: Rabbit and Human Studies
Dutta, D., Ozkan, J., & Willcox, M. D. P. (2014) · Optometry and Vision Science · doi:10.1097/opx.0000000000000232 · Cited by 73
Aoki, N., Ishii, Y., Tateda, K., Saga, T., Kimura, S., Kikuchi, Y., Kobayashi, T., Tanabe, Y., Tsukada, H., Gejyo, F., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00511-10 · Cited by 73
Characterization of Enterococcus faecium bacteriophage IME-EFm5 and its endolysin LysEFm5
Gong, P., Cheng, M., Li, X., Jiang, H., Yu, C., Kahaer, N., Li, J., Zhang, L., Xia, F., Hu, L., et al. (2016) · Virology · doi:10.1016/j.virol.2016.02.006 · Cited by 73
Morimoto, K., Ozawa, T., Awazu, K., Ito, N., Honda, N., Matsumoto, S., & Tsuruta, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105173 · Cited by 72
dos Santos, A. L. S., Sodré, C. L., Valle, R. S., da Silva, B. A. S., Abi-chacra, É. A., Silva, L. V., Souza-Gonçalves, A. L., Sangenito, L. S., Gonçalves, D. D. S., Souza, L. O., et al. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800609788 · Cited by 72
Yoshizumi, A., Ishii, Y., Kimura, S., Saga, T., Harada, S., Yamaguchi, K., Kazuhiro, T., Livermore, D. M., Woodford, N., & Livermore, D. M. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0528-y · Cited by 71
Human Salivary Protein Histatin 5 Has Potent Bactericidal Activity against ESKAPE Pathogens
Du, H., Puri, S., McCall, A. D., Norris, H. L., Russo, T. A., & Edgerton, M. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00041 · Cited by 71
El-Azizi, M., Din, S. N. E., El-Tayeb, T. A.-A., & Abou‐Aisha, K. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s102398 · Cited by 70
Optimizing Antimicrobial Therapy of Sepsis and Septic Shock: Focus on Antibiotic Combination Therapy
Vázquez‐Grande, G., & Kumar, A. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0034-1398742 · Cited by 66
Chaudhari, A. A., Ashmore, D., Nath, S. D., Kate, K. H., Dennis, V. A., Singh, S. R., Owen, D. R., Palazzo, C., Arnold, R. D., Miller, M. E., et al. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0211-z · Cited by 65
Rineh, A., Dolla, N. K., Ball, A. R., Magana, M., Bremner, J. B., Hamblin, M. R., Tegos, G. P., & Kelso, M. J. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00095 · Cited by 63
Biological responses of silver-coated thermosets: An in vitro and in vivo study
Marsich, E., Travan, A., Donati, I., Turco, G., Kulkova, J., Moritz, N., Aro, H. T., Crosera, M., & Paoletti, S. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.10.002 · Cited by 62
Flury, B. B., Ellington, M. J., Hopkins, K. L., Turton, J. F., Doumith, M., Loy, R., Staves, P., Hinić, V., Frei, R., & Woodford, N. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02835-15 · Cited by 61
Cappiello, F., Grazia, A. D., Segev-Zarko, L.-A. T., Scali, S., Ferrera, L., Galietta, L. J. V., Pini, A., Shai, Y., Di, Y. P., & Mangoni, M. L. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00904-16 · Cited by 60
Liu, S., Long, Q., Xu, Y., Wang, J., Xu, Z., Wang, L., Zhou, M., Wu, Y., Chen, T., & Shaw, C. (2017) · Oncotarget · doi:10.18632/oncotarget.22797 · Cited by 58
Pompilio, A., Geminiani, C., Bosco, D., Rana, R., Aceto, A., Bucciarelli, T., Scotti, L., & Bonaventura, G. D. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01349 · Cited by 58
Singh, R., Vora, J. K., Nadhe, S. B., Wadhwani, S. A., Shedbalkar, U. U., & Chopade, B. A. (2017) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2018.15013 · Cited by 54
Otvos, L. J., Ostorházi, E., Szabó, D., Zumbrun, S. D., Miller, L. L., Halasohoris, S. A., Desai, P. D., Veldt, S. M. I., & Kraus, C. N. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00309 · Cited by 54
The Potential of Phage Therapy in Sepsis
Górski, A., Jończyk‐Matysiak, E., Łusiak-Szelachowska, M., Międzybrodzki, R., Weber‐Dąbrowska, B., & Borysowski, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01783 · Cited by 50
Wypij, M., Świecimska, M., Czarnecka, J., Dahm, H., Rai, M., & Golińska, P. (2018) · Journal of Applied Microbiology · doi:10.1111/jam.13723 · Cited by 47
Preliminary survey of local bacteriophages with lytic activity against multi‐drug resistant bacteria
Latz, S., Wahida, A., Arif, A., Häfner, H., Hoß, M., Ritter, K., & Horz, H. (2016) · Journal of Basic Microbiology · doi:10.1002/jobm.201600108 · Cited by 46
Nakonieczna, J., Wolnikowska, K., Ogonowska, P., Neubauer, D., Bernat, A., & Kamysz, W. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01949 · Cited by 46
Zhao, Y., Lu, Z., Dai, X., Wei, X., Yu, Y., Chen, X., Zhang, X., & Li, C. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00600 · Cited by 46
Silver Nanocoatings for Reducing the Exogenous Microbial Colonization of Wound Dressings
Rădulescu, M., Andronescu, E., Dolete, G., Popescu, R. C., Fufă, O. M., Chifiriuc, M. C., Mogoantă, L., Bălşeanu, T. A., Mogoşanu, G. D., Grumezescu, A. M., et al. (2016) · Materials · doi:10.3390/ma9050345 · Cited by 45
Chen, C., Mangoni, M. L., & Di, Y. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-08361-8 · Cited by 44
Yang, M., Chang, K., Chen, L.-Y., Wang, P.-C., Chou, C.-C., Wu, Z.-B., & Hu, A. (2018) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2018.02.003 · Cited by 43
Iramiot, J. S., Kajumbula, H., Bazira, J., Kansiime, C., Rwego, I. B., & Asiimwe, B. B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200093 · Cited by 43
Identification, Characterization, Immunolocalization, and Biological Activity of Lucilin Peptide
Ramírez, G. A. T., Zapata, J. A., Toro, L. J., Henao, D. C., Agudelo, J. P. B., Rivera, J. D., Trujillo, J. V., Rivas-Santiago, B. T., Lopez, R. O. H., & Osório, J. C. C. (2018) · Acta Tropica · doi:10.1016/j.actatropica.2018.06.003 · Cited by 42
Pan Drug-Resistant Environmental Isolate of Acinetobacter baumannii from Croatia
Goić-Barišić, I., Musić, M. Š., Kovačić, A., Tonkić, M., & Hrenović, J. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2016.0229 · Cited by 41
Greimel, F., Scheuerer, C., Gessner, A., Simon, M., Kalteis, T., Grifka, J. K., Benditz, A., Springorum, H.-R., & Schaumburger, J. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s138888 · Cited by 41
Golińska, P., Wypij, M., Rathod, D., Tikar, S., Dahm, H., & Rai, M. (2015) · Journal of Basic Microbiology · doi:10.1002/jobm.201500516 · Cited by 40
Snyder, A. D. H., Werth, B. J., Nonejuie, P., McRoberts, J. P., Pogliano, J., Sakoulas, G., Yim, J., Singh, N. B., & Rybak, M. J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00687-16 · Cited by 40
Kuo, Y.-L., Wang, S.-G., Wu, C.-Y., Lee, K.-C., Jao, C.-J., Chou, S.-H., & Chen, Y. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0232 · Cited by 40
Bueno, J. (2016) · Journal of Microbial & Biochemical Technology · doi:10.4172/1948-5948.1000281 · Cited by 38
Yang, H., Xu, J., Li, W., Wang, S., Li, J., Yu, J., Li, Y., & Wei, H. (2018) · The EMBO Journal · doi:10.15252/embj.201798045 · Cited by 38
Nigo, M., Díaz, L., Carvajal, L. P., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01235-16 · Cited by 36
Anti-infective efficacy of the lactoferrin-derived antimicrobial peptide HLR1r
Björn, C., Mahlapuu, M., Mattsby‐Baltzer, I., & Håkansson, J. (2016) · Peptides · doi:10.1016/j.peptides.2016.04.005 · Cited by 35
Rineh, A., Bremner, J. B., Hamblin, M. R., Ball, A. R., Tegos, G. P., & Kelso, M. J. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.02.041 · Cited by 35
Enhancing Whole Phage Therapy and Their Derived Antimicrobial Enzymes through Complex Formulation
Cooper, C. J., Koonjan, S., & Nilsson, A. S. (2018) · Pharmaceuticals · doi:10.3390/ph11020034 · Cited by 35
Moon, S. H., Zhang, X., Zheng, G., Meeker, D. G., Smeltzer, M. S., & Huang, E. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01064 · Cited by 34
Mohapatra, D. P., Debata, N. K., & Singh, S. K. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.08.010 · Cited by 33
Katayama, B., Ozawa, T., Morimoto, K., Awazu, K., Ito, N., Honda, N., Oiso, N., & Tsuruta, D. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.03.001 · Cited by 32
Rishi, P., Vashist, T., Sharma, A., Kaur, A., Kaur, A., Kaur, N., Kaur, I. P., & Tewari, R. (2018) · Pathogens and Disease · doi:10.1093/femspd/fty072 · Cited by 32
Gandt, A. B., Griffith, E. C., Lister, I., Billings, L. L., Han, A., Tangallapally, R. P., Zhao, Y., Singh, A. P., Lee, R. E., Jr., & LaFleur, M. D. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00424-18 · Cited by 30
Clinical efficacy of fosfomycin combinations against a variety of gram-positive cocci
Coronado-Álvarez, N. M., Parra, D., & Parra-Ruiz, J. (2018) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2018.05.009 · Cited by 30
Chen, H., Su, P.-Y., Kuo, S., Lauderdale, T.-L. Y., & Shih, C. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01440 · Cited by 25
Ostorházi, E., Hoffmann, R., Herth, N., Wade, J. D., Kraus, C. N., & Otvos, L. J. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00359 · Cited by 23
Prakash, V., Mishra, P., Premi, H., Walia, A., Dhawan, S., & Kumar, A. (2014) · International Journal of Research in Medical Sciences · doi:10.5455/2320-6012.ijrms20141111 · Cited by 22
Wang, Y., Harrington, O. D., Wang, Y., Murray, C. K., Hamblin, M. R., & Dai, T. (2017) · Journal of Visualized Experiments · doi:10.3791/54997 · Cited by 22
Optimization of Antimicrobial Photodynamic Therapy in Biofilms by Inhibiting Efflux Pump
Coletti, T. M. S. F. D. A., de Freitas, L. M., Fusco‐Almeida, A. M., & Fontana, C. R. (2017) · Photomedicine and Laser Surgery · doi:10.1089/pho.2016.4246 · Cited by 22
Irani, N., Basardeh, E., Samiee, F., Fateh, A., Shooraj, F., Rahimi, A., Shahcheraghi, F., Vaziri, F., Masoumi, M., Pazhouhandeh, M., et al. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.05.051 · Cited by 22
Defraine, V., Verstraete, L., Françoise Van Bambeke, A., Anantharajah, A., Townsend, E. R., Ramage, G., Corbau, R., Marchand, A., Chaltin, P., Fauvart, M., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02585 · Cited by 15
Alakeel, R. A., Mateen, A., Syed, R., Alqahtani, M. S., & Alqahtani, A. S. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.05.010 · Cited by 15
Maliszewska, I., Kałas, W., Wysokińska, E., Tylus, W., Pietrzyk, N., Popko, K., & Palewska, K. (2017) · Lasers in Medical Science · doi:10.1007/s10103-017-2337-0 · Cited by 14
Cited by
Understanding bacterial biofilms: From definition to treatment strategies
Zhao, A., Sun, J., & Liu, Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1137947 · Cited by 743
Acinetobacter baumannii Antibiotic Resistance Mechanisms
Kyriakidis, I., Vasileiou, E., Pana, Z. D., & Tragiannidis, A. (2021) · Pathogens · doi:10.3390/pathogens10030373 · Cited by 678
Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics
Murugaiyan, J., Kumar, P. A., Rao, G. S., Iskandar, K., Hawser, S., Hays, J. P., Mohsen, Y., Adukkadukkam, S., Awuah, W. A., Jose, R. A. M., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11020200 · Cited by 567
Gan, B. H., Gaynord, J., Rowe, S. M., Deingruber, T., & Spring, D. R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00729c · Cited by 511
Discovery of antimicrobial peptides in the global microbiome with machine learning
Santos-Júnior, C. D., Torres, M. D. T., Duan, Y., Rodríguez del Río, Á., Schmidt, T. S. B., Chong, H., Fullam, A., Kuhn, M., Zhu, C., Houseman, A., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.013 · Cited by 419
Metadata
- Authors
- Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2019-04-01
- Volume
- 10
- Pages
- 539-539
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2934656438
- Cited by
- 1,644
- References
- 176
- FWCI
- 50.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.